What is LAVA Therapeutics NV Price-to-Free-Cash-Flow?
As of today (2024-06-09), LAVA Therapeutics NV's share price is $2.29.
LAVA Therapeutics NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.19. Hence, LAVA Therapeutics NV's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for LAVA Therapeutics NV's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 5 years, LAVA Therapeutics NV's highest Price-to-Free-Cash-Flow Ratio was 31.56. The lowest was 5.22. And the median was 17.08.
LVTX's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.545 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of LAVA Therapeutics NV was -1368.10% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -56.60% per year.
During the past 5 years, LAVA Therapeutics NV's highest 3-Year average Free Cash Flow per Share Growth Rate was -56.60% per year. The lowest was -56.60% per year. And the median was -56.60% per year.
LAVA Therapeutics NV Price-to-Free-Cash-Flow Historical Data
The historical data trend for LAVA Therapeutics NV's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LAVA Therapeutics NV's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, LAVA Therapeutics NV's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LAVA Therapeutics NV's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where LAVA Therapeutics NV's Price-to-Free-Cash-Flow falls into.
LAVA Therapeutics NV's Share Price of today is $2.29. LAVA Therapeutics NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
LAVA Therapeutics NV Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of LAVA Therapeutics NV's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LVTX has been successfully added to your 